A ProPublica investigation reveals the dangerous effects of contrast agents patients are injected with before receiving an MRI screening. One, Omniscan, can leaves behind traces of gadolinium that cannot be excreted by persons with kidney diseases. While the FDA did determine the agent should not be used in people with severe kidney diseases, Omniscan has still been found to leave a damaging mark on even healthy bodies.
From the story:
“The new studies… have set off alarms because they show that even patients with healthy kidneys are retaining gadolinium from Omniscan and Magnevist. Estimates are that about one-third of the 20 million MRIs in the United States each year use one of the nine contrast agents.”
Read the full story here.